UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 398

Sortiert nach

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

Nature medicine, 2010-02, Vol.16 (2), p.205-213

2010

Volltextzugriff (PDF)

Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy

Clinical cancer research, 2012-05, Vol.18 (9), p.2603-2612

2012

Volltextzugriff (PDF)

Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment

Blood, 2012-09, Vol.120 (13), p.2679-2689

2012

Volltextzugriff (PDF)

PI3K: from the bench to the clinic and back

Current topics in microbiology and immunology, 2010, Vol.347, p.1

2010

Volltextzugriff (PDF)

PI3K and cancer: lessons, challenges and opportunities

Nature reviews. Drug discovery, 2014-02, Vol.13 (2), p.140-156

2014

Volltextzugriff (PDF)

Defining the role of TORC1/2 in multiple myeloma

Blood, 2011-12, Vol.118 (26), p.6860-6870

2011

Volltextzugriff (PDF)

Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt

Science (American Association for the Advancement of Science), 1999-11, Vol.286 (5445), p.1738-1741

1999

Volltextzugriff (PDF)

Phosphoinositide 3-kinases as targets for therapeutic intervention

Current pharmaceutical design, 2004-01, Vol.10 (16), p.1915

2004

Volltextzugriff (PDF)

Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (4), p.1251-1256

2012

Volltextzugriff (PDF)

PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?

Nature reviews. Immunology, 2007-03, Vol.7 (3), p.191-201

2007

Volltextzugriff (PDF)

Ras controls growth, survival and differentiation in the Drosophila eye by different thresholds of MAP kinase activity

Development (Cambridge), 2001-05, Vol.128 (9), p.1687-1696

2001

Volltextzugriff (PDF)

Kennzahlenbasiertes F & E-Controlling im Kontext der Elektromobilität: Methodische Erarbeitung eines Kennzahlengerüsts für das operative F & E-Controlling am Beispiel eines Maschinen- und Anlagenbauers

Zeitschrift für wirtschaftlichen Fabrikbetrieb, 2022-03, Vol.117 (3), p.133-138

2022

Volltextzugriff (PDF)

Convergent Functional Genomics of Oligodendrocyte Differentiation Identifies Multiple Autoinhibitory Signaling Circuits

Molecular and Cellular Biology, 2009-03, Vol.29 (6), p.1538-1553

2009

Volltextzugriff (PDF)

PI3 kinase regulation of skeletal muscle hypertrophy and atrophy

Current topics in microbiology and immunology, 2010-01, Vol.346, p.267

Glass, David J

2010

Volltextzugriff (PDF)

Oncogenic mutations of PIK3CA in human cancers

Current topics in microbiology and immunology, 2010-01, Vol.347, p.21

2010

Volltextzugriff (PDF)

Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth

The Journal of biological chemistry, 2007-11, Vol.282 (48), p.35405-35415

2007

Volltextzugriff (PDF)

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic

Cancer discovery, 2011-12, Vol.1 (7), p.562-572

2011

Volltextzugriff (PDF)

A Chemical Proteomics Approach to Phosphatidylinositol 3-Kinase Signaling in Macrophages

Molecular & cellular proteomics, 2007-11, Vol.6 (11), p.1829-1841

2007

Volltextzugriff (PDF)

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses

Nature reviews. Drug discovery, 2007-05, Vol.6 (5), p.391-403

2007

Volltextzugriff (PDF)

The translational landscape of mTOR signalling steers cancer initiation and metastasis

Nature (London), 2012-05, Vol.485 (7396), p.55-61

2012

Volltextzugriff (PDF)

PI3Kγ inhibition: towards an 'aspirin of the 21st century'?

Nature reviews. Drug discovery, 2006-11, Vol.5 (11), p.903-918

2006

Volltextzugriff (PDF)

Taking PI3Kδ and PI3Kγ one step ahead: dual active PI3Kδ/γ inhibitors for the treatment of immune-mediated inflammatory diseases

Current topics in microbiology and immunology, 2010, Vol.346, p.279

Rommel, Christian

2010

Volltextzugriff (PDF)

Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway

Current topics in microbiology and immunology, 2010, Vol.346, p.31

2010

Volltextzugriff (PDF)

Key role of the p110δ isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells

Blood, 2006-01, Vol.107 (2), p.642-650

2006

Volltextzugriff (PDF)

Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

Nature medicine, 2005-09, Vol.11 (9), p.936-943

2005

Volltextzugriff (PDF)

1 – 25 von 398

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(348)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(236)
Life Sciences & Biomedicine
(203)
Humans
(133)
Animals
(94)
Cardiovascular System & Cardiology
(71)
Cardiac & Cardiovascular Systems
(67)
Mice
(48)
Female
(47)
Male
(46)
Immunology
(38)
Heart Failure
(34)
Microbiology
(31)
Signal Transduction
(30)
Treatment Outcome
(29)
Biochemistry & Molecular Biology
(27)
Phosphatidylinositol 3-Kinases - Physiology
(27)
Aged
(26)
Biological And Medical Sciences
(24)
Phosphatidylinositol 3-Kinases - Antagonists & Inhibitors
(24)
Middle Aged
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy

Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment

PI3K: from the bench to the clinic and back

PI3K and cancer: lessons, challenges and opportunities

Defining the role of TORC1/2 in multiple myeloma

Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt

Phosphoinositide 3-kinases as targets for therapeutic intervention

Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis

PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?

Ras controls growth, survival and differentiation in the Drosophila eye by different thresholds of MAP kinase activity

Kennzahlenbasiertes F & E-Controlling im Kontext der Elektromobilität: Methodische Erarbeitung eines Kennzahlengerüsts für das operative F & E-Controlling am Beispiel eines Maschinen- und Anlagenbauers

Convergent Functional Genomics of Oligodendrocyte Differentiation Identifies Multiple Autoinhibitory Signaling Circuits

PI3 kinase regulation of skeletal muscle hypertrophy and atrophy

Oncogenic mutations of PIK3CA in human cancers

Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic

A Chemical Proteomics Approach to Phosphatidylinositol 3-Kinase Signaling in Macrophages

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses

The translational landscape of mTOR signalling steers cancer initiation and metastasis

PI3Kγ inhibition: towards an 'aspirin of the 21st century'?

Taking PI3Kδ and PI3Kγ one step ahead: dual active PI3Kδ/γ inhibitors for the treatment of immune-mediated inflammatory diseases

Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway

Key role of the p110δ isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells

Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

Suchergebnisse filtern